Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro

Journal of Steroid Biochemistry and Molecular Biology

Volumn 141, Issue , 2014, Pages 94-103

  Deb, Subrata ^a   Chin, Mei Yieng ^a   Adomat, Hans ^a   Guns, Emma S Tomlinson ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

CYP3A4; Ginsenosides; Inhibition; Interaction; Microsomes; Vitamin D3

Indexed keywords

AGLYCONE; AZAMULIN; CALCITRIOL; CYTOCHROME P450 3A4; GINSENOSIDE; KETOCONAZOLE; MIDAZOLAM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; ENZYME ANALYSIS; FOLLOW UP; GINSENG; HUMAN; HUMAN CELL; HYDROXYLATION; IC 50; INTESTINE; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; LIVER; METABOLIC INHIBITION; MICROSOME; NONHUMAN; TANDEM MASS SPECTROMETRY; VITAMIN METABOLISM;

CYP3A4; GINSENOSIDES; INHIBITION; INTERACTION; MICROSOMES; VITAMIN D(3);

BIOTRANSFORMATION; CALCITRIOL; CYTOCHROME P-450 CYP3A; HUMANS; INTESTINES; KINETICS; MICROSOMES, LIVER; MIDAZOLAM; SAPOGENINS;

EID: 84896699321     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.01.007     Document Type: Article

References (61)

1. S. Christakos, M. Hewison, D.G. Gardner, C.L. Wagner, I.N. Sergeev, E. Rutten, A.G. Pittas, R. Boland, L. Ferrucci, and D.D. Bikle Vitamin D: beyond bone Ann. N. Y. Acad. Sci. 1287 2013 45 58
2. C. Annweiler, and O. Beauchet Vitamin D-mentia: randomized clinical trials should be the next step Neuroepidemiology 37 2011 249 258
3. S. Battault, S.J. Whiting, S.L. Peltier, S. Sadrin, G. Gerber, and J.M. Maixent Vitamin D metabolism, functions and needs: from science to health claims Eur. J. Nutr. 52 2013 429 441
4. R. Zhang, and D.P. Naughton Vitamin D in health and disease: current perspectives Nutr. J. 9 2010 65
5. A. Verstuyf, G. Carmeliet, R. Bouillon, and C. Mathieu Vitamin D: a pleiotropic hormone Kidney Int. 78 2010 140 145
6. K.K. Deeb, D.L. Trump, and C.S. Johnson Vitamin D signalling pathways in cancer: potential for anticancer therapeutics Nat Rev Cancer 7 2007 684 700 (Pubitemid 47327412)
7. T.M. Beer, C.W. Ryan, P.M. Venner, D.P. Petrylak, G.S. Chatta, J.D. Ruether, C.H. Redfern, L. Fehrenbacher, M.N. Saleh, D.M. Waterhouse, M.A. Carducci, D. Vicario, R. Dreicer, C.S. Higano, F.R. Ahmann, K.N. Chi, W.D. Henner, A. Arroyo, and F.W. Clow Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators J. Clin. Oncol. 25 2007 669 674 (Pubitemid 350002922)
8. J.R. Muindi, Y. Peng, D.M. Potter, P.A. Hershberger, J.S. Tauch, M.J. Capozzoli, M.J. Egorin, C.S. Johnson, and D.L. Trump Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel Clin. Pharmacol. Ther. 72 2002 648 659 (Pubitemid 36021004)
9. J.R. Sigmon, B.A. Yentzer, and S.R. Feldman Calcitriol ointment: a review of a topical vitamin D analog for psoriasis J. Dermatolog. Treat 20 2009 208 212
10. D.E. Prosser, and G. Jones Enzymes involved in the activation and inactivation of vitamin D Trends Biochem. Sci. 29 2004 664 673 (Pubitemid 39491265)
11. Y.R. Lou, F. Molnar, M. Perakyla, S. Qiao, A.V. Kalueff, R. St-Arnaud, C. Carlberg, and P. Tuohimaa 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand J. Steroid Biochem. Mol. Biol. 118 2010 162 170
12. R.A. Shellhaas, A.K. Barks, and S.M. Joshi Prevalence and risk factors for vitamin D insufficiency among children with epilepsy Pediatr. Neurol. 42 2010 422 426
13. J.E. Isenor, and M.H. Ensom Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk? Pharmacotherapy 30 2010 254 264
14. S. Deb, M. Pandey, H. Adomat, and E.S. Guns Cytochrome P450 3A-mediated microsomal biotransformation of 1alpha,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism Drug Metab. Dispos. 40 2012 907 918
15. M.R. Haussler, P.W. Jurutka, M. Mizwicki, and A.W. Norman Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms Best Pract. Res. Clin. Endocrinol. Metab. 25 2011 543 559
16. G. Jones Extrarenal vitamin d activation and interactions between vitamin d2, vitamin d3, and vitamin d analogs Annu. Rev. Nutr. 33 2013 23 44
17. Z. Wang, E.G. Schuetz, Y. Xu, and K.E. Thummel Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 J. Steroid Biochem. Mol. Biol. 136 2013 54 58
18. S.F. Zhou Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4 Curr. Drug Metab. 9 2008 310 322
19. Y. Xu, T. Hashizume, M.C. Shuhart, C.L. Davis, W.L. Nelson, T. Sakaki, T.F. Kalhorn, P.B. Watkins, E.G. Schuetz, and K.E. Thummel Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia Mol. Pharmacol. 69 2006 56 65 (Pubitemid 43048893)
20. J. Qiu 'Back to the future' for Chinese herbal medicines Nat. Rev. Drug Discov. 6 2007 506 507 (Pubitemid 47019438)
21. V.A. Assinewe, B.R. Baum, D. Gagnon, and J.T. Arnason Phytochemistry of wild populations of Panax quinquefolius L. (North American ginseng) J. Agric. Food Chem. 51 2003 4549 4553
22. K.T. Choi Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer Acta Pharmacol. Sin. 29 2008 1109 1118
23. J.M. Lu, Q. Yao, and C. Chen Ginseng compounds: an update on their molecular mechanisms and medical applications Curr. Vasc. Pharmacol. 7 2009 293 302
24. S.F. Chu, and J.T. Zhang New achievements in ginseng research and its future prospects Chin. J. Integr. Med. 15 2009 403 408
25. T.W. Chan, P.P. But, S.W. Cheng, I.M. Kwok, F.W. Lau, and H.X. Xu Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS Anal. Chem. 72 2000 1281 1287 (Pubitemid 30163787)
26. H. Hasegawa Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid J. Pharmacol. Sci. 95 2004 153 157 (Pubitemid 38899683)
27. E.A. Bae, M.J. Han, M.K. Choo, S.Y. Park, and D.H. Kim Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities Biol. Pharm. Bull. 25 2002 58 63
28. S. Shibata Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds J. Korean Med. Sci. 16 Suppl. 2001 S28 S37
29. H.C. Ren, J.G. Sun, G.J. Wang, J.Y. A, H.T. Xie, W.B. Zha, B. Yan, F.Z. Sun, H.P. Hao, S.H. Gu, L.S. Sheng, F. Shao, J. Shi, and F. Zhou Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats J. Pharmaceut. Biomed. Anal. 48 2008 1476 1480
30. H. Hao, L. Lai, C. Zheng, Q. Wang, G. Yu, X. Zhou, L. Wu, P. Gong, and G. Wang Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship Drug Metab. Dispos. 38 2010 1731 1739
31. L. Li, X. Chen, D. Li, and D. Zhong Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes Drug Metab. Dispos. 39 2011 472 483
32. H. Dang, Y. Chen, X. Liu, Q. Wang, L. Wang, W. Jia, and Y. Wang Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression Progr. Neuro-psychopharmacol. Biol. Psychiatry 33 2009 1417 1424
33. N.T. Chiu, E.S. Guns, H. Adomat, W. Jia, and S. Deb Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol Biopharm. Drug Dispos. 2013 (in press)
34. A.G. Musende, A. Eberding, C. Wood, H. Adomat, L. Fazli, A. Hurtado-Coll, W. Jia, M.B. Bally, and E.T. Guns Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy Cancer Chemother. Pharmacol. 64 2009 1085 1095
35. A.G. Musende, A. Eberding, C.A. Wood, H. Adomat, L. Fazli, A. Hurtado-Coll, W. Jia, M.B. Bally, and E.S. Tomlinson Guns A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer Anticancer Drugs 23 2012 543 552
36. E.S. Perloff, A.K. Mason, S.S. Dehal, A.P. Blanchard, L. Morgan, T. Ho, A. Dandeneau, R.M. Crocker, C.M. Chandler, N. Boily, C.L. Crespi, and D.M. Stresser Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design Xenobiotica 39 2009 99 112
37. M. Ben-Shoshan Vitamin D deficiency/insufficiency and challenges in developing global vitamin D fortification and supplementation policy in adults Int J Vitam Nutr Res 82 2012 237 259
38. M.D. Sitrin, K.L. Pollack, and M.J. Bolt Intestinal absorption of 1,25-dihydroxyvitamin D3 in the rat Am. J. Physiol. 248 1985 G718 G725
39. G.L. Henderson, M.R. Harkey, M.E. Gershwin, R.M. Hackman, J.S. Stern, and D.M. Stresser Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity Life Sci. 65 1999 PL209 PL214
40. Y. Liu, J.W. Zhang, W. Li, H. Ma, J. Sun, M.C. Deng, and L. Yang Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes Toxicol. Sci. 91 2006 356 364 (Pubitemid 43827288)
41. N. He, and T. Edeki The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes Am. J. Ther. 11 2004 206 212
42. Y. Liu, H. Ma, J.W. Zhang, M.C. Deng, and L. Yang Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes Planta Med. 72 2006 126 131 (Pubitemid 43293866)
43. R.W. Wang, D.J. Newton, N. Liu, W.M. Atkins, and A.Y. Lu Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent Drug Metab. Dispos. 28 2000 360 366 (Pubitemid 30137063)
44. Z. Wang, Y.S. Lin, L.J. Dickmann, E.J. Poulton, D.L. Eaton, J.W. Lampe, D.D. Shen, C.L. Davis, M.C. Shuhart, and K.E. Thummel Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia J. Bone Miner. Res. 28 2013 1101 1116
45. Y.J. He, Z.Z. Fang, G.B. Ge, P. Jiang, H.Z. Jin, W.D. Zhang, and L. Yang The inhibitory effect of 20(S)-protopanaxatriol (ppt) towards UGT1A1 and UGT2B7 Phytother. Res. 27 2013 628 632
46. D. Wagner, D. Trudel, T. Van der Kwast, L. Nonn, A.A. Giangreco, D. Li, A. Dias, M. Cardoza, S. Laszlo, K. Hersey, L. Klotz, A. Finelli, N. Fleshner, and R. Vieth Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients J. Clin. Endocrinol. Metab. 98 2013 1498 1507
47. P. Jiang, W.Y. Zhang, H.D. Li, H.L. Cai, Y.P. Liu, and L.Y. Chen Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats Psychoneuroendocrinology 2013
48. J. Welsh Vitamin D metabolism in mammary gland and breast cancer Mol. Cell Endocrinol. 347 2011 55 60
49. P. Bareis, G. Bises, M.G. Bischof, H.S. Cross, and M. Peterlik 25-Hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression Biochem. Biophys. Res. Commun. 285 2001 1012 1017 (Pubitemid 32918038)
50. C. Ghosh, N. Marchi, N.K. Desai, V. Puvenna, M. Hossain, J. Gonzalez-Martinez, A.V. Alexopoulos, and D. Janigro Cellular localization and functional significance of CYP3A4 in the human epileptic brain Epilepsia 52 2011 562 571
51. J.A. Agundez, C. Martinez, M. Olivera, L. Gallardo, J.M. Ladero, C. Rosado, J. Prados, J. Rodriguez-Molina, L. Resel, and J. Benitez Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk Br. J. Cancer 78 1998 1361 1367 (Pubitemid 28495251)
52. X.E. Zheng, Z. Wang, M.Z. Liao, Y.S. Lin, M.C. Shuhart, E.G. Schuetz, and K.E. Thummel Human PXR-mediated induction of intestinal CYP3A4 attenuates 1alpha,25-dihydroxyvitamin D(3) function in human colon adenocarcinoma LS180 cells Biochem. Pharmacol. 84 2012 391 401
53. A.G. Musende, A. Eberding, W. Jia, E. Ramsay, M.B. Bally, and E.T. Guns Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer The Prostate 70 2010 1437 1447
54. X. Xie, A. Eberding, C. Madera, L. Fazli, W. Jia, L. Goldenberg, M. Gleave, and E.S. Guns Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models J. Urol. 175 2006 1926 1931
55. J.C.M. Han, Y. Wang, S. Chen, and X. Wang Determination of 20(S)-protopanaxadiol in rat plasma by LC-MS/MS and its application to the pharmacokinetic study: a comparative study of its solution and two oral formulations J. Anal. Chem. 68 2013 730 735
56. H. Hasegawa, J.H. Sung, S. Matsumiya, and M. Uchiyama Main ginseng saponin metabolites formed by intestinal bacteria Planta Med. 62 1996 453 457 (Pubitemid 26370341)
57. D. Zhang, Y. Wang, J. Han, W. Yu, L. Deng, J.P. Fawcett, Z. Liu, and J. Gu Rapid and sensitive LC-MS/MS assay for the quantitation of 20(S)-protopanaxadiol in human plasma J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 877 2009 581 585
58. L. Li, X. Chen, J. Zhou, and D. Zhong In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9 Drug Metab. Dispos. 40 2012 2041 2053
59. H. Liu, J. Yang, F. Du, X. Gao, X. Ma, Y. Huang, F. Xu, W. Niu, F. Wang, Y. Mao, Y. Sun, T. Lu, C. Liu, B. Zhang, and C. Li Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats Drug Metab. Dispos. 37 2009 2290 2298
60. M. Ingelman-Sundberg Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future Trends Pharmacol. Sci. 25 2004 193 200 (Pubitemid 38519910)
61. M.R. Harkey, G.L. Henderson, M.E. Gershwin, J.S. Stern, and R.M. Hackman Variability in commercial ginseng products: an analysis of 25 preparations Am. J. Clin. Nutr. 73 2001 1101 1106 (Pubitemid 32496951)